I en ny studie, utført i flere europeiske land, er det undersøkt om legemiddelet Sulodexide kan forebygge at man får en ny blodpropp etter å først ha fått én. Etter at man har fått en blodpropp vil man få behandling med blodfortynnende medisin. For noen pasienter er dessverre risikoen for indre blødninger for stor med denne behandlingen, og behandlingen blir derfor avsluttet etter 3-12 måneder. Det ...

The following protocol is an outline of the method we use to prepare Kupffer cells (KC) and liver sinusoidal endothelial cells (LSEC) from mouse liver. The method is based on the one originally published to prepare rat liver KC and LSEC (1), and is slightly modified from the one outlined in (2). We also strongly recommend reading our 2012 review paper (3) to obtain a solid background understanding ...

The use of complementary and alternative medicine (CAM) in oncology settings is widespread. Improving CAM-related communication within the sphere of conventional cancer care is crucial to patient safety, optimal treatment outcomes and the patient’s trust in healthcare professionals. Studies have revealed, however, that only a few oncologists and physicians feel comfortable discussing CAM ...

Intervju med Camilla Johansen om Pårørendeprosjektet i Bodø kommune.